Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuroendocrine peptide acting on VPAC1 and VPAC2 Class B GPCRs, investigated in pulmonary vasodilation, circadian SCN synchronization, and microglial anti-inflammatory models.
Scientific Profile & Research Key Points: VIP
Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuroendocrine peptide acting on VPAC1 and VPAC2 Class B GPCRs, investigated in pulmonary vasodilation, circadian SCN synchronization, and microglial anti-inflammatory models.
Active Batch Release Specifications (Lot SL-2026-166)
Analytical release verification for current VIP (5 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-166 | 2026-10-28 | RP-HPLC (C18, 214nm) + ESI-MS | ≥99.0% (Single Peak) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile 0.9% Bacteriostatic Water or neutral PBS (pH 7.0–7.4)
Temperature & Stability
Store lyophilized at -20°C under nitrogen (protect Met17 from oxidation); refrigerate solution at 2°C–8°C.
VIP — Technical Questions & Answers
What is the molar concentration when reconstituting VIP (5 mg) in 2.0 mL?
Reconstituting the full 5 mg vial of VIP (MW 3325.80 g/mol) in 2.0 mL of diluent produces a 2.50 mg/mL stock solution — equivalent to approximately 0.75 mM (752 µM) gross molarity before Net Peptide Content (NPC) adjustment.
How does VIP's counterion stoichiometry affect assay mass calculations?
VIP (CAS 40077-57-4, formula C147H238N44O42S) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.
Which analytical methods verify VIP Lot SL-2026-166 and what pathway does it target?
Lot SL-2026-166 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 3325.80 g/mol. In preclinical literature, VIP targets VPAC1 & VPAC2 (Class B GPCRs) — neuroimmune & circadian signaling (Delgado M. & Ganea D., Trends Mol Med (2013) — Vasoactive intestinal peptide neuroimmune regulation (PMID: 23415022)).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
How to Read a Peptide Certificate of Analysis (COA): Step-by-Step Breakdown
A practical guide for researchers. How to analyze HPLC chromatograms, verify retention time, interpret mass spec m/z peaks, evaluate counterion salt ratios, and spot fraudulent documents.
How to Reconstitute Research Peptides: Complete Laboratory Protocol and Best Practices
Standard Operating Procedure (SOP) for peptide reconstitution. Diluent selection (BAC water vs acetic acid), meniscus calculations, avoiding foaming, and cold storage parameters.
Peptide Storage and Stability: A Comprehensive Laboratory Guide
Analytical protocols for preserving lyophilized and reconstituted peptides. Temperature zones (-80°C, -20°C, 4°C), freeze-thaw degradation, hygroscopicity, and photostability.